Clinical Trials Directory

Trials / Completed

CompletedNCT00240110

Valproate Efficacy in Cocaine-Bipolar Comorbidity

Status
Completed
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
152 (actual)
Sponsor
University of Miami · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

This proposal will test the efficacy of a promising pharmacological approach for the treatment of comorbid cocaine dependence and bipolar disorder. We propose a randomized, double blind, placebo controlled 12-week trial to test the efficacy of Divalproex sodium (Valproate) plus treatment as usual compared to placebo plus treatment as usual in decreasing cocaine use and stabilizing mood symptoms among patients with comorbid cocaine dependence and bipolar disorder. Treatment as usual includes the use of lithium carbonate for mood stabilization plus supportive psychosocial treatment.

Detailed description

Bipolar disorder has the highest rate of association with cocaine and other substance use disorders than any other major severe psychiatric syndrome. This comorbidity represents a major treatment challenge and is associated with severe disability, morbidity, and heightened risk for suicide. The aims of this study are: 1. Examine the efficacy of valproate plus treatment as usual compared to placebo plus treatment as usual in decreasing cocaine use in patients with cocaine dependence and comorbid bipolar disorder. 2. Determine whether primary vs. secondary cocaine dependence, bipolar subtype (depressed vs. manic/mixed) and the presence of additional substance use disorders moderate the association between treatment and cocaine use outcome. 3. Assess the effects of medication compliance and mood symptoms as mediators of cocaine use outcome.

Conditions

Interventions

TypeNameDescription
DRUGValproateValproate with dose titration to achieve blood levels within the therapeutic range
DRUGPlaceboControl arm
DRUGLithium CarbonateAll participants were started and stabilized on lithium carbonate as a standard treatment for bipolar disorder

Timeline

Start date
2006-03-01
Primary completion
2014-03-01
Completion
2014-03-01
First posted
2005-10-17
Last updated
2016-10-17
Results posted
2016-10-17

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00240110. Inclusion in this directory is not an endorsement.